Skip to main content

Table 2 Eligibility Criteria.

From: A randomized, controlled, prospective trial to evaluate the haemostatic effect of Lyostypt versus Surgicel in arterial bypass anastomosis: "COBBANA" trial

INCLUSION CRITERIA

EXCLUSION CRITERIA

• Patients > 18 years

• Emergency surgery

• Informed Consent

• Patients with coagulopathy or uremia

• Indication for a peripheral vascular reconstruction due to peripheral vascular disease

• Participating in another trial with interfering endpoints

• Suture hole bleeding of peripheral arterial bypass anastomosis using PTFE graft

• Patients requiring continuous postoperative anticoagulation

 

• Reoperation within one month at the same location

 

• Pregnant and breastfeeding women

 

• Known or suspected allergies or hypersensitivity to any of the used devices

 

• Severe comorbidity (ASA >4)

 

• Life expectancy less than 12 months

 

• Current immunsuppressive therapy

 

• Chemotherapy within last 4 weeks

 

• Severe psychiatric or neurologic diseases

 

• Lack of compliance

 

• Drug- and/alcohol-abuse

 

• Inability to understand and to follow the instructions given by the investigator